GlassScriptPhysician profile
Lubow O Lewicky
NPI 1124013685
$276.47
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $62.66 | 2019 | |
| Duchesnay USA Incorporated | $41.54 | 2019 | |
| Hologic Sales and Service, LLC | $30.14 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.75 | 2019 | |
| Merck Sharp & Dohme LLC | $24.02 | 2019 | |
| Therapeuticsmd, INC. | $23.08 | 2019 | |
| Astellas Pharma US INC | $20.44 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.87 | 2019 | |
| Pfizer INC. | $13.90 | 2019 | |
| Lupin INC. | $13.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lubow Lewicky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.